Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma

Alessandro Larcher, Umberto Capitanio, Carlo Terrone, Alessandro Volpe, Paolo De Angelis, Federico Dehó, Nicola Fossati, Paolo Dell'Oglio, Alessandro Antonelli, Maria Furlan, Claudio Simeone, Sergio Serni, Marco Carini, Andrea Minervini, Cristian Fiori, Francesco Porpiglia, Alberto Briganti, Francesco Montorsi, Roberto Bertini

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Purpose: There is no consensus regarding a protective effect on mortality due to a cause other than cancer in patients treated with elective nephron sparing surgery relative to their radical nephrectomy counterparts. We test whether the protective effect of nephron sparing surgery relative to radical nephrectomy is universal or present in specific subgroups of patients. Materials and Methods: A collaborative database of 5 institutions was queried to evaluate 1,783 patients without chronic kidney disease diagnosed with a clinical T1 renal mass that was treated with nephron sparing surgery or radical nephrectomy. Multivariable Cox regression analysis was done to assess the impact of surgery type (nephron sparing surgery vs radical nephrectomy) on other cause mortality after adjustment for patient and cancer characteristics. Interaction terms were used to test the hypothesis that the impact of surgery type varies according to specific subcohorts of patients. Results: Ten-year other cause mortality-free survival rates were 90% and 88% after nephron sparing surgery and radical nephrectomy, respectively. In the overall population radical nephrectomy was not associated with an increased risk of other cause mortality on multivariable analysis compared to nephron sparing surgery (HR 0.91, 95% CI 0.6-1.38, p = 0.6). However, radical nephrectomy increased the risk of other cause mortality according to the increasing baseline Charlson comorbidity index (interaction test p = 0.0008). For example, in a patient with a Charlson comorbidity index of 4 the probability of 10-year other cause mortality-free survival was 86% after nephron sparing surgery and 60% after radical nephrectomy. Conclusions: Elective nephron sparing surgery does not improve other cause survival relative to radical nephrectomy consistently in all patients with kidney cancer. Patients who are more ill with relevant comorbidities are those who benefit the most from nephron sparing surgery in terms of other cause mortality.

Original languageEnglish
JournalJournal of Urology
DOIs
Publication statusAccepted/In press - 2016

Fingerprint

Nephrons
Nephrectomy
Renal Cell Carcinoma
Mortality
Comorbidity
Survival
Kidney Neoplasms
Chronic Renal Insufficiency
Neoplasms
Survival Rate
Regression Analysis
Databases
Kidney

Keywords

  • Carcinoma, renal cell
  • Cause of death
  • Comorbidity
  • Kidney
  • Nephrectomy

ASJC Scopus subject areas

  • Urology

Cite this

Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma. / Larcher, Alessandro; Capitanio, Umberto; Terrone, Carlo; Volpe, Alessandro; De Angelis, Paolo; Dehó, Federico; Fossati, Nicola; Dell'Oglio, Paolo; Antonelli, Alessandro; Furlan, Maria; Simeone, Claudio; Serni, Sergio; Carini, Marco; Minervini, Andrea; Fiori, Cristian; Porpiglia, Francesco; Briganti, Alberto; Montorsi, Francesco; Bertini, Roberto.

In: Journal of Urology, 2016.

Research output: Contribution to journalArticle

Larcher, A, Capitanio, U, Terrone, C, Volpe, A, De Angelis, P, Dehó, F, Fossati, N, Dell'Oglio, P, Antonelli, A, Furlan, M, Simeone, C, Serni, S, Carini, M, Minervini, A, Fiori, C, Porpiglia, F, Briganti, A, Montorsi, F & Bertini, R 2016, 'Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma', Journal of Urology. https://doi.org/10.1016/j.juro.2016.04.093
Larcher, Alessandro ; Capitanio, Umberto ; Terrone, Carlo ; Volpe, Alessandro ; De Angelis, Paolo ; Dehó, Federico ; Fossati, Nicola ; Dell'Oglio, Paolo ; Antonelli, Alessandro ; Furlan, Maria ; Simeone, Claudio ; Serni, Sergio ; Carini, Marco ; Minervini, Andrea ; Fiori, Cristian ; Porpiglia, Francesco ; Briganti, Alberto ; Montorsi, Francesco ; Bertini, Roberto. / Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma. In: Journal of Urology. 2016.
@article{f84bb62fad604d7ebfeb8cd289e74f7d,
title = "Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma",
abstract = "Purpose: There is no consensus regarding a protective effect on mortality due to a cause other than cancer in patients treated with elective nephron sparing surgery relative to their radical nephrectomy counterparts. We test whether the protective effect of nephron sparing surgery relative to radical nephrectomy is universal or present in specific subgroups of patients. Materials and Methods: A collaborative database of 5 institutions was queried to evaluate 1,783 patients without chronic kidney disease diagnosed with a clinical T1 renal mass that was treated with nephron sparing surgery or radical nephrectomy. Multivariable Cox regression analysis was done to assess the impact of surgery type (nephron sparing surgery vs radical nephrectomy) on other cause mortality after adjustment for patient and cancer characteristics. Interaction terms were used to test the hypothesis that the impact of surgery type varies according to specific subcohorts of patients. Results: Ten-year other cause mortality-free survival rates were 90{\%} and 88{\%} after nephron sparing surgery and radical nephrectomy, respectively. In the overall population radical nephrectomy was not associated with an increased risk of other cause mortality on multivariable analysis compared to nephron sparing surgery (HR 0.91, 95{\%} CI 0.6-1.38, p = 0.6). However, radical nephrectomy increased the risk of other cause mortality according to the increasing baseline Charlson comorbidity index (interaction test p = 0.0008). For example, in a patient with a Charlson comorbidity index of 4 the probability of 10-year other cause mortality-free survival was 86{\%} after nephron sparing surgery and 60{\%} after radical nephrectomy. Conclusions: Elective nephron sparing surgery does not improve other cause survival relative to radical nephrectomy consistently in all patients with kidney cancer. Patients who are more ill with relevant comorbidities are those who benefit the most from nephron sparing surgery in terms of other cause mortality.",
keywords = "Carcinoma, renal cell, Cause of death, Comorbidity, Kidney, Nephrectomy",
author = "Alessandro Larcher and Umberto Capitanio and Carlo Terrone and Alessandro Volpe and {De Angelis}, Paolo and Federico Deh{\'o} and Nicola Fossati and Paolo Dell'Oglio and Alessandro Antonelli and Maria Furlan and Claudio Simeone and Sergio Serni and Marco Carini and Andrea Minervini and Cristian Fiori and Francesco Porpiglia and Alberto Briganti and Francesco Montorsi and Roberto Bertini",
year = "2016",
doi = "10.1016/j.juro.2016.04.093",
language = "English",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma

AU - Larcher, Alessandro

AU - Capitanio, Umberto

AU - Terrone, Carlo

AU - Volpe, Alessandro

AU - De Angelis, Paolo

AU - Dehó, Federico

AU - Fossati, Nicola

AU - Dell'Oglio, Paolo

AU - Antonelli, Alessandro

AU - Furlan, Maria

AU - Simeone, Claudio

AU - Serni, Sergio

AU - Carini, Marco

AU - Minervini, Andrea

AU - Fiori, Cristian

AU - Porpiglia, Francesco

AU - Briganti, Alberto

AU - Montorsi, Francesco

AU - Bertini, Roberto

PY - 2016

Y1 - 2016

N2 - Purpose: There is no consensus regarding a protective effect on mortality due to a cause other than cancer in patients treated with elective nephron sparing surgery relative to their radical nephrectomy counterparts. We test whether the protective effect of nephron sparing surgery relative to radical nephrectomy is universal or present in specific subgroups of patients. Materials and Methods: A collaborative database of 5 institutions was queried to evaluate 1,783 patients without chronic kidney disease diagnosed with a clinical T1 renal mass that was treated with nephron sparing surgery or radical nephrectomy. Multivariable Cox regression analysis was done to assess the impact of surgery type (nephron sparing surgery vs radical nephrectomy) on other cause mortality after adjustment for patient and cancer characteristics. Interaction terms were used to test the hypothesis that the impact of surgery type varies according to specific subcohorts of patients. Results: Ten-year other cause mortality-free survival rates were 90% and 88% after nephron sparing surgery and radical nephrectomy, respectively. In the overall population radical nephrectomy was not associated with an increased risk of other cause mortality on multivariable analysis compared to nephron sparing surgery (HR 0.91, 95% CI 0.6-1.38, p = 0.6). However, radical nephrectomy increased the risk of other cause mortality according to the increasing baseline Charlson comorbidity index (interaction test p = 0.0008). For example, in a patient with a Charlson comorbidity index of 4 the probability of 10-year other cause mortality-free survival was 86% after nephron sparing surgery and 60% after radical nephrectomy. Conclusions: Elective nephron sparing surgery does not improve other cause survival relative to radical nephrectomy consistently in all patients with kidney cancer. Patients who are more ill with relevant comorbidities are those who benefit the most from nephron sparing surgery in terms of other cause mortality.

AB - Purpose: There is no consensus regarding a protective effect on mortality due to a cause other than cancer in patients treated with elective nephron sparing surgery relative to their radical nephrectomy counterparts. We test whether the protective effect of nephron sparing surgery relative to radical nephrectomy is universal or present in specific subgroups of patients. Materials and Methods: A collaborative database of 5 institutions was queried to evaluate 1,783 patients without chronic kidney disease diagnosed with a clinical T1 renal mass that was treated with nephron sparing surgery or radical nephrectomy. Multivariable Cox regression analysis was done to assess the impact of surgery type (nephron sparing surgery vs radical nephrectomy) on other cause mortality after adjustment for patient and cancer characteristics. Interaction terms were used to test the hypothesis that the impact of surgery type varies according to specific subcohorts of patients. Results: Ten-year other cause mortality-free survival rates were 90% and 88% after nephron sparing surgery and radical nephrectomy, respectively. In the overall population radical nephrectomy was not associated with an increased risk of other cause mortality on multivariable analysis compared to nephron sparing surgery (HR 0.91, 95% CI 0.6-1.38, p = 0.6). However, radical nephrectomy increased the risk of other cause mortality according to the increasing baseline Charlson comorbidity index (interaction test p = 0.0008). For example, in a patient with a Charlson comorbidity index of 4 the probability of 10-year other cause mortality-free survival was 86% after nephron sparing surgery and 60% after radical nephrectomy. Conclusions: Elective nephron sparing surgery does not improve other cause survival relative to radical nephrectomy consistently in all patients with kidney cancer. Patients who are more ill with relevant comorbidities are those who benefit the most from nephron sparing surgery in terms of other cause mortality.

KW - Carcinoma, renal cell

KW - Cause of death

KW - Comorbidity

KW - Kidney

KW - Nephrectomy

UR - http://www.scopus.com/inward/record.url?scp=84992699517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992699517&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2016.04.093

DO - 10.1016/j.juro.2016.04.093

M3 - Article

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

ER -